PAM
TRVI icon

Panagora Asset Management’s Trevi Therapeutics TRVI Stock Holding History

Panagora Asset Management’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.46M Sell
625,578
-67,423
-10% -$755K 0.03% 346
2025
Q4 		$8.68M Buy
693,001
+122,533
+21% +$1.42M 0.03% 311
2025
Q3 		$5.22M Buy
570,468
+766
+0.1% +$5.74K 0.02% 358
2025
Q2 		$3.12M Buy
569,702
+229,798
+68% +$1.43M 0.01% 395
2025
Q1 		$2.14M Buy
339,904
+219,600
+183% +$1.05M 0.01% 494
2024
Q4 		$496K Buy
120,304
+95,403
+383% +$305K ﹤0.01% 840
2024
Q3 		$83.2K Buy
+24,901
New +$74K ﹤0.01% 1183
2020
Q2 		– Sell
-406
Closed -$1K – 2653
2020
Q1 		$1K Hold
406
– – ﹤0.01% 2455
2019
Q4 		$2K Hold
406
– – ﹤0.01% 2364
2019
Q3 		$2K Buy
+406
New +$2.21K ﹤0.01% 2376

Other funds holding TRVI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return